Misonix to acquire Solsys Medical for approximately $97 million

Misonix, Inc. has entered into a definitive agreement to acquire Solsys Medical, LLC, a regenerative medical company, in an all-stock transaction valued at approximately $97 million. The combined entity is expected to generate over $80 million in annual revenue for fiscal 2020.

“Misonix, Inc. (Nasdaq: MSON) (“Misonix”) a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, announced today that it has entered into a definitive agreement with Solsys Medical, LLC (“Solsys”), a privately held regenerative medical company, to acqu”globenewswire.com

• 1 source
• globenewswire.comMisonix, Inc. Enters Into Definitive Agreement to AcquireMISONIX, Inc.May 2, 2019

Summarized from public sources; check the original articles before acting on it.